Singer H H, Gates F T, Kindt T J, Williamson A R
Eur J Immunol. 1980 May;10(5):346-51. doi: 10.1002/eji.1830100506.
A messenger RNA fraction from the C 3 H mouse myeloma 5563 was used to direct the synthesis of heavy (gamma 2a) and light (chi) chain precursors. The synthetic products were radiolabeled by inclusion of [3H] or [35S] amino acids in wheat-germ cell-free translation system. Precursor peptides for both H and L chains were indicated by comparison by polyacrylamide gel analysis of apparent molecular weights of chains synthesized in vitro vs. in vivo. The nonglycosylated H chain synthesized in vivo in the presence of tunicamycin was used for comparison. This approach should be generally applicable for the demonstration of precursor forms of N-glycosylated polypeptides. Following immunoprecipitation and preparative polyacrylamide gel electrophoresis, the isolated chains were subjected to automated Edman degradation. The amino acid sequence data obtained for these precursors were significantly different from those reported for BALB/c immunoglobulins. The 5563 H chain precursor bears little homology to the previously reported H chain precursor from MOPC 315 (IgA) (Jilka, J. A. and Pestka, S., Proc. Nat. Acad. Sci. USA 1977. 74:5692). The 5563 H chain can be assigned to a heretofore undescribed H chain variable region subgroup on the basis of partial sequence data. The amino terminal sequence of the 5563 L chain precursor has maximum homology (25-50%) to the ssequence o the precursor peptide of MOPC 41 chi chain.
来自C3H小鼠骨髓瘤5563的信使RNA组分被用于指导重链(γ2a)和轻链(χ)前体的合成。通过在无细胞小麦胚芽翻译系统中加入[3H]或[35S]氨基酸,对合成产物进行放射性标记。通过聚丙烯酰胺凝胶分析比较体外和体内合成链的表观分子量,确定了重链和轻链的前体肽。在衣霉素存在下体内合成的非糖基化重链被用作对照。这种方法通常可用于证明N-糖基化多肽的前体形式。经过免疫沉淀和制备性聚丙烯酰胺凝胶电泳后,对分离出的链进行自动Edman降解。从这些前体获得的氨基酸序列数据与报道的BALB/c免疫球蛋白的数据有显著差异。5563重链前体与先前报道的来自MOPC 315(IgA)的重链前体(Jilka,J.A.和Pestka,S.,《美国国家科学院院刊》1977年。74:5692)几乎没有同源性。根据部分序列数据,5563重链可归属于一个迄今未描述的重链可变区亚组。5563轻链前体的氨基末端序列与MOPC 41 χ链前体肽的序列具有最大同源性(25-50%)。